FDA Eyes Social Media Data, ASCO Touts EHRs As Post-Market Tool

The American Society of Clinical Oncology this week urged Congress to take steps to promote interoperability of electronic health records and prevent the practice of “information blocking,” while touting its CancerLinQ initiative that will harness big data analytics, and could potentially help FDA use real-world data to make decisions around medical products. This comes after FDA, the University of Maryland’s Center for Excellence in Regulatory Science Innovation and the Center for Health Information and Decision Systems at a workshop last...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.